QC
BDSI

QCM Cayman’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

QCM Cayman’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-11,253
Closed -$35K – 67
2019
Q1 		$35K Buy
+11,253
New +$51.4K 0.67% 29

Other funds holding BDSI

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

QCM Cayman's BDSI Position: Q2 2019 in Review

QCM Cayman sold out of BioDelivery Sciences International, Inc. (BDSI) in Q2 2019, closing a stake of 11,253 shares — an estimated $35K sold.

QCM Cayman first reported a position in BDSI in Q1 2019 and held it in 1 quarter. The position peaked at $35K in Q1 2019. 110 funds tracked by Wall St. Rank hold BDSI as of Q2 2019.

  • QCM Cayman reported no remaining BioDelivery Sciences International, Inc. position as of Q2 2019 after selling out during the quarter.
  • QCM Cayman sold 11,253 BioDelivery Sciences International, Inc. shares in Q2 2019, an estimated $35K.
  • QCM Cayman first reported a position in BioDelivery Sciences International, Inc. in Q1 2019 and held it in 1 quarter.
  • QCM Cayman's BioDelivery Sciences International, Inc. position peaked at $35K in Q1 2019.
  • 110 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q2 2019.

Based on QCM Cayman's 13F filing for Q2 2019, filed 14 Aug 2019.